Sinopharm Group Co. Ltd. (HKG:1099)
15.45
-0.22 (-1.40%)
Oct 22, 2026, 3:40 PM HKT
Sinopharm Group Market Cap
Sinopharm Group has a market cap or net worth of 48.21 billion as of October 21, 2026. It is the 3,114th most valuable company in the world and the 163rd biggest in Hong Kong. Its market cap has decreased by 17.47% in one year.
Market Cap
48.21B
Enterprise Value
165.30B
Revenue
660.27B
Global Rank
Country Rank
#163 Hong Kong
PE Ratio
5.90
ChartMarket Cap Chart
Since September 23, 2009, Sinopharm Group's market cap has increased from 40.42B to 48.21B, an increase of 19.27%. That is a compound annual growth rate of 1.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 48.21B | -20.52% |
| Dec 31, 2025 | 60.67B | -8.73% |
| Dec 31, 2024 | 66.47B | 4.16% |
| Dec 29, 2023 | 63.82B | 3.07% |
| Dec 30, 2022 | 61.91B | 16.98% |
| Dec 31, 2021 | 52.93B | -10.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Guanze Medical Information Industry (Holding) | 2.62B |
| Sipai Health Technology | 978.23M |
| 160 Health International | 837.77M |
| Charmacy Pharmaceutical | 593.46M |
| ETHK Labs | 545.46M |
| China Health Group | 374.53M |
| Sinco Pharmaceuticals Holdings | 294.77M |
| ClouDr Group | 287.34M |